01/06/2025

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

01/06/2025

Jun 1, 2025, 14:41 | Insight
Aakash Desai: Interim Results from Our Phase 1 Trial of PDL1V, a Vedotin-Based ADC Targeting PD-L1 in R/R NSCLC at ASCO 2025
Aakash Desai, Assistant Professor and Associate Director of Phase 1 and Precision Oncology Program at…
Jun 1, 2025, 14:40 | Blog
Conversations That Shape Science: Insights from Denver Danfeng Li - The Babak Lab
The Babak Lab shared a post on LinkedIn: "Conversations That Shape Science: Insights from Denver…
Jun 1, 2025, 14:39 | Blog
Christina Ip-Toma: Integrating germline and tumor genetic results to reduce disparities in cancer care
Christina Ip-Toma, Director of Scientific Programs at MIB Agents Osteosarcoma Alliance, shared on LinkedIn: "Integrating germline…
Jun 1, 2025, 14:38 | Blog
Key Insights by Petros Grivas from ASCO25
At ASCO 2025, Dr. Petros Grivas offered insightful commentary on several impactful studies that are…
Jun 1, 2025, 14:38 | Science
Kriti Mittal: The ASCO special edition of the ASPIRE CoP newsletter
Kriti Mittal, GU Medical Oncologist at UMass Memorial Health, shared a post by ASPIRE on X,…
Jun 1, 2025, 13:48 | Oncolibrary
Romiplostim for Chemotherapy-induced Thrombocytopenia Results from global phase iii trial in Gi cancers
From May 30 to June 3, 2025, the ASCO Annual Meeting will bring together thousands…
Jun 1, 2025, 13:42 | Opinion
Efficacy of IL-6R Blockade with Sarilumab in a Quadruple Immuno-Oncology Regimen for Patients with Unresectable Stage III/IV Melanoma
The ASCO Annual Meeting 2025 is happening from May 30 to June 3 in Chicago.…
Jun 1, 2025, 13:02 | Oncolibrary
CheckMate 214 Trial Final 9-Year Results at ASCO 2025: Nivolumab Plus Ipilimumab Continues to Show Long-Term Survival Benefit in Advanced Renal Cell Carcinoma
Presented by Dr. Robert J. Motzer at ASCO 2025, the final 9-year follow-up results from…
Jun 1, 2025, 12:40 | Oncolibrary
Metacure Cohorts B2 Results: Intensified Hormonal Blockade and SBRT for PSMA-PET Detected Oligometastatic Prostate Adenocarcinoma
The ASCO Annual Meeting 2025 is happening from May 30 to June 3 in Chicago.…
Jun 1, 2025, 12:10 | Blog
Luca Arecco: Sac-TMT Shows Promising Efficacy in Advanced TNBC as 1st-Line Therapy
Luca Arecco, Clinical Research Fellow at ESMO, posted on X: "Rapid oral mBC  OptiTROP-Breast05: Sac-TMT…
All: 145 Posts: 41 - 50
Special Coverage